Steroid News and Research

RSS

Translaminar technique reduces neck pain without significant risk of paralysis

In the largest series of patients to date, recent research shows that the translaminar approach to cervical spinal steroid injections can reduce neck pain in eighty-three percent of those treated.

5 Mar 2007

Preemie lung treatments turn out to be safe

Preemies between 28 and 32 weeks are not harmed by a treatment no longer used to help their lungs mature before birth, according to findings of a study in this month's Pediatrics.

5 Mar 2007

Steroid use fails to boost pregnancy rates in infertility treatments

There is no clear benefit from a hormone commonly prescribed to enhance the effectiveness of infertility treatments, according to a new review of studies.

1 Mar 2007

Use of growth hormone to boost athletic performance can lead to diabetes

The study reports the case of a 36 year old professional body-builder who required emergency care for chest pain.

27 Feb 2007

Use of growth hormone to boost athletic performance can lead to diabetes

The study reports the case of a 36 year old professional body-builder who required emergency care for chest pain.

26 Feb 2007

FDA wants warning label on omalizumab (Xolair)

The Food and Drug Administration (FDA) announced that it has requested Genentech, Inc. add a boxed warning to the product label for omalizumab, marketed as Xolair.

21 Feb 2007

Regulator of cholesterol production identified

By first probing the way primitive yeast make cholesterol, a team of scientists has discovered a long-sought protein whose human counterpart controls cholesterol production and potentially drug metabolism.

20 Feb 2007

Injections with "dermal fillers" containing hyaluronic acid may partially restore sun-damaged skin

Injectable skin fillers have become increasingly popular for correcting the lines and wrinkles associated with aging, as well as acne scars and other skin conditions, according to background information in the article.

20 Feb 2007

Prospective cardiac monitoring in fetuses at risk of congenital heart block

There is an increased risk of fetal heart problems when mothers carry particular antibodies associated with rheumatic diseases, according to an abstract presented by Yale School of Medicine researchers at the Society for Maternal-Fetal Medicine Conference in San Francisco.

11 Feb 2007

Vitamin D 'tops' for cancer prevention

Two new vitamin D studies using a sophisticated form of analysis called meta-analysis, in which data from multiple reports is combined, have revealed new prescriptions for possibly preventing up to half of the cases of breast cancer and two-thirds of the cases of colorectal cancer in the United States.

6 Feb 2007

Time, therapy spur recovery from sudden sensorineural hearing loss

A first-of-its-kind study into time-dependent treatments of sudden sensorineural hearing loss published in the February 2007 issue of Otolaryngology- Head and Neck Surgery has determined that a combination of time and oral corticosteroid therapy can play a key role in helping patients regain full hearing, often within a month of the initial loss of hearing.

29 Jan 2007

Anabolic steroids and antisocial behaviour go together

Swedish researchers have found that there could well be a link between the use of anabolic steroids and antisocial behaviour.

7 Nov 2006

Squalenoyl nanomedicines as potential therapeutics

Nucleoside analogs such as cytarabine and gemcitabine are powerful anticancer agents, but a simple chemical modification that causes them to assemble into stable nanoparticles could make them even more valuable in the treatment of a wide variety of cancers.

23 Oct 2006

New York Times examines efforts to obtain FDA approval for Abraxane to treat earlier-stage cancer

The New York Times has examined efforts by the pharmaceutical company Abraxis BioScience to obtain FDA approval for its late-stage breast cancer drug Abraxane as a treatment for earlier-stage breast cancer.

5 Oct 2006

Progesterone improves outcomes for victims of traumatic brain injury

A new study suggests that giving progesterone to victims with Traumatic Brain Injury (TBI) shortly following brain injury may reduce the risk of death and the degree of disability, and appears to be safe.

3 Oct 2006

Treatments used for SARS no benefit to victims

Researchers have found, following a systematic review of all studies done on the 2003 SARS epidemic, that none of the treatments used to treat patients appear to have worked.

13 Sep 2006

Inhaled corticosteroids reduce COPD mortality risk

Patients with chronic obstructive pulmonary disease (COPD) who use inhaled corticosteroids may have a significantly decreased mortality risk, according to a new study published in the September issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP).

12 Sep 2006